Loading viewer...
investor_presentation
Format: PDF investor_presentation
Lonza Group Ltd announced the acquisition of Capsugel to accelerate growth across the healthcare continuum. The deal, presented in December 2016, combines Lonza's pharmaceutical and biotech capabilities with Capsugel's capsule and dosage form technologies. This strategic acquisition strengthens Lonza's position as an integrated supplier across pharmaceutical manufacturing and life sciences sectors.
ESB Green Bond Roadshow 2019 Presentation
investor_presentationinvestor_presentation
30 Pages
Electricity Supply Board (ESB)
investor_presentation
Sinch
Constellation Pharmaceuticals Investor Presentation — October 2020
investor_presentationinvestor_presentation
32 Pages
Constellation Pharmaceuticals